MedTrace Logo

Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial

NCT00852592 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2016-11-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to understand the efficacy of light therapy for bipolar depression.

Conditions

Interventions

DEVICE

7000lux broad-spectrum light

dosage - 15-60minutes NOON-2PM daily

DEVICE

50lux dim red light

dosage: 15-60minutes NOON-2PM daily

Sponsors & Collaborators

Principal Investigators

  • Dorothy K Sit, M.D. · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-05-31
Primary Completion
2014-12-31
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00852592 on ClinicalTrials.gov